• Clinical Insights: May 5, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Darzalex FasproTM (daratumumab and hyaluronidase-fihj) Injection – New Drug Approval – May 1, 2020 –  The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food… Read more »

  • Clinical Insights: April 30, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Ongentys® (opicapone) Capsules – New Drug Approval – April 27, 2020 – Neurocrine Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral… Read more »

  • Clinical Insights: April 24, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval TukysaTM (tucatinib) – New Drug Approval – April 17, 2020 – As part of Project Orbis, the U.S. Food and Drug Administration approved TukysaTM (tucatinib) in combination with chemotherapy… Read more »

  • Clinical Insights: April 16, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Koselugo® (selumetinib) – New Drug Approval – April 10, 2020 – The U.S. Food and Drug Administration approved Koselugo® (selumetinib) for the treatment of pediatric patients, 2 years… Read more »

  • Clinical Insights: April 9, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Sevenfact® (coagulation factor VIIa [recombinant]-jncw) – New Drug Approval – April 1, 2020 – The U.S. Food and Drug Administration approved Sevenfact® [coagulation factor VIIa (recombinant)-jncw] for the treatment and… Read more »

  • Clinical Insights: April 1, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Zeposia® (ozanimod) Capsules – New Drug Approval – March 26, 2020 – Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) approved Zeposia® (ozanimod) 0.92… Read more »

  • Clinical Insights: March 24, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Isturisa® (osilodrostat) Tablets – New Orphan Drug Approval – March 6, 2020 – The U.S. Food and Drug Administration announced the approval of Isturisa® (osilodrostat)… Read more »

  • Happy Holidays!

      Happy Holidays from the RxStrategies team! Wishing you a time filled with fun and joy. Best wishes for the New Year!   Warm Regards, The RxStrategies Team

  • Clinical Insights: September 30, 2019

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Jynneos™ (smallpox and monkeypox vaccine, live, nonreplicating) – New Vaccine Approval – September 24, 2019 – The U.S. Food and Drug Administration announced the approval… Read more »

  • Let’s Connect: APHCA Annual Conference and Expo

    RxStrategies is proud to be a Platinum Presenting Sponsor of Alabama Primary Health Care Association’s (APHCA) Annual Bootcamp, Conference and Expo. The event is the State’s largest annual gathering of community health systems, providers and partners from across the community of care. This year’s annual event, Taking Point, will be held on October 1-3, 2019 at… Read more »